Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1084 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Benralizumab for Chronic Obstructive Pulmonary Disease (COPD)	Benralizumab (Fasenra; MEDI563)	Chronic obstructive pulmonary disease (COPD)	Respiratory System	2017	View \| Download
Benegrastim for treating chemotherapy-induced neutropenia in women with breast cancer	Benegrastim	Breast cancer	Breast Cancer , Immunology , Toxicology	2022	View \| Download
Bempegaldesleukin in combination with nivolumab for previously untreated unresectable or metastatic melanoma	Bempegaldesleukin (NKTR-214; BMS-986321; NEKTAR) , Nivolumab (Opdivo; BMS-936558; ONO-4538)	Melanoma	Skin Cancer	2022	View \| Download
Bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia in patients unable to reach cholesterol goals with the maximum tolerated dose of a statin	Bempedoic acid (ETC-1002; Nilemdo)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Belzutifan for von Hippel-Lindau disease-associated clear cell renal cell carcinoma – first line	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Genetic Disorders , Oncology , Renal Cancer	2021	View \| Download
Belzutifan for advanced or metastatic clear cell renal cell carcinoma after 1 therapy	Belzutifan (PT2977; MK-6482)	Renal cell carcinoma (RCC)	Renal Cancer	2022	View \| Download
Belumosudil for graft versus host disease	Belumosudil (SLx-2119; KD025; KD-025)	Graft versus host disease (GvHD)	Immunology	2021	View \| Download
Belinostat (Beleodaq) with CHOP for treatment of patients with peripheral T‐cell lymphoma, 1st line	Belinostat (Beleodaq; PXD101) , CHOP	Peripheral T-cell lymphoma (PTCL)	Haematological Cancer and Lymphomas	2017	View \| Download